Novimmune raises CHF60 million

Novimmune S.A. (Plan-les-Ouates, Switzerland) raised CHF60 million ($67.3 million) in an extension of a series B round led by new investor Rosetta Capital. Undisclosed new and existing investors also participated in the extension. Including the most recent extension, Novimmune has raised CHF220 million ($246.6 million) in the B round since 2005. Rosetta's Jonathan Hepple joined the company's board. ...